Baloxavir Marboxil
Baloxavir Marboxil (S-033188, Xofluza) is the prodrug of Baloxavir acid (S-033447) that potently and selectively inhibits the cap-dependent endonuclease within the polymerase PA subunit of influenza A and B viruses. Influenza Approved (In Vitro) :Baloxavir marboxil is a polymerase acidic protein (PA) endonuclease inhibitor.
Product Specifications
CAS Number
1985606-14-1
Product Name Alternative
S-033188 | Xofluza
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 50 mg/mL 87.48 mM
Smiles
O=C (OCOC (C (C=C1) =O) =C (N1N ([C@@H]2C3=CC=CC=C3SCC4=C (F) C (F) =CC=C24) [C@@]5 ([H]) N6CCOC5) C6=O) OC
Molecular Formula
C27H23F2N3O7S
Molecular Weight
571.552
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
({ (12aR) -12-[ (11S) -7,8-difluoro-6,11-dihydrodibenzo[b, e]thiepin-11-yl]-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl}oxy) methyl methyl carbonate
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog